AVLN — Avalyn Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Avalyn Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -49.7 | -85.2 |
| Depreciation | ||
| Non-Cash Items | -0.013 | 1.07 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 1.36 | 2.61 |
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -48.4 | -81.5 |
| Capital Expenditures | -0.095 | -0.344 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | -91.4 | 10.4 |
| Change in Net Investments | ||
| Cash from Investing Activities | -91.5 | 10.1 |
| Financing Cash Flow Items | 0.038 | 99.8 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 0.089 | 99.8 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -140 | 28.4 |